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Genetically modified Lactococcus lactis, non-pathogenic bacteria expressing the FNIII7-10 fibronectin
fragment as a protein membrane have been used to create a living biointerface between synthetic materials
and mammalian cells. This FNIII7-10 fragment comprises the RGD and PHSRN sequences of fibronectin to
bind a5b1 integrins and triggers signalling for cell adhesion, spreading and differentiation.We used L. lactis
strain to colonize material surfaces and produce stable biofilms presenting the FNIII7-10 fragment readily
available to cells. Biofilm density is easily tunable and remains stable for several days. Murine C2C12
myoblasts seeded over mature biofilms undergo bipolar alignment and form differentiated myotubes, a
process triggered by the FNIII7-10 fragment. This biointerface based on living bacteria can be further
modified to express any desired biochemical signal, establishing a new paradigm in biomaterial surface
functionalisation for biomedical applications.
U
nderstanding the behaviour of cells on synthetic surfaces is of foremost interest to engineer microenvir-
onments that direct cell adhesion, proliferation and differentiation. To favour the interaction with cells,
surfaces of synthetic biomaterials have been functionalized with a broad range of proteins, fragments,
peptides and growth factors including fibronectin (FN), laminin, vitronectin and others, by using physical and
chemical strategies1–3. However, these passive coatings can by no means provide the dynamic stimuli required to
orchestrate cell responses and organise the formation of a new tissue at the material interface. Significant efforts
have focused on engineeringmaterials that recapitulate characteristics of the ECM, such as the presentation of cell
adhesive motifs or protease degradable cross-links, in order to direct cellular responses4,5. Photoactivable RGD
adhesive peptides were used to investigate the effect of the density and time point of ligand presentation on cell
adhesion, proliferation and differentiation6. Similarly, enzyme-responsive surfaces that present cell adhesive
RGD sequences on-demand, that is, by enzymatic hydrolysis of inactive RGD containing precursors that carry
cleavable steric blocking groups, have been used to spatiotemporal controlled attachment of cells7. However, the
development of a cell/material interface able to provide biological stimuli upon demand, a functional dynamic
interface between stem cells and synthetic materials, has not been established yet. We hypothesised that non-
pathogenic bacteria can colonise the surface of a broad range of synthetic materials and can be genetically
modified to constitutively express or secrete the desired adhesive proteins and factors to a living cell population
upon external demand. This work shows that non-pathogenic bacteria that constitutively express a fibronectin
fragment enhance cell differentiation. However, our long-term goal is to transform this living interface into a
dynamic system able to secrete other proteins and growth factors upon demand.
We have recently shown that genetically modified, non-pathogenic bacteria, can play the role of a (living)
biointerface betweenmammalian cells and synthetic biomaterials and we chose Lactococcus lactis subsp. cremoris
as host for membrane expression of the fibronectin FNIII7-10 fragment8. This fragment contains the RGD
adhesion motif (10th repeat of the type III fragment) and the PHSRN synergy site (9th repeat of type III fragment),
both of them necessary to promote a5b1 integrin mediated adhesion9. Lactococcus lactis is a gram-positive, non-
pathogenic bacterium, with GRAS (Generally Regarded as Safe) status and with low production of exopolysac-
charides, a mandatory condition to ensure the accessibility of the displayed FNIII7-10 fragments on the bacteria
membrane. Moreover, this low exopolysaccharide production is not an obstacle for this strain to develop stable
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biofilms: these bacteria firmly attach to synthetic surfaces and estab-
lish communities10,11. This results in a stable layer of bacteria on the
material surface which present FNIII7-10 fragments8.
Mammalian cells interact with FN via integrins, a family of
transmembrane receptor proteins that anchor them to the ECM.
Integrin-mediated adhesion is a complex process that involves the
organization of focal adhesion clusters that link the ECM to the
cytoskeleton. Focal complexes are mature adhesion sites that con-
tains structural proteins (vinculin, paxilin, talin, tensin) and signal-
ling molecules (FAK, focal adhesion kinase, Src)3,12,13. We have
previously shown that FN null fibroblasts (FN -/-) adhered on this
living biointerface based on L. lactis expressing FNIII7-10, develop
focal adhesions and promote FAK-based signalling8.
This work investigates the potential of this living interface based
on L. lactis expressing a FN fragment as amembrane protein to direct
cell differentiation by evaluatingmyogenic differentiation14. As prev-
iously reported8, a modified L.lactis (MG1363) was engineered to
express FNIII7-10 as amembrane protein. The used construct features
the Usp45 secretion peptide, GFP and the FNIII7-10 fragment con-
taining the RGD adhesion (module III10) and PHSRN synergy site
(module III9). The construct is anchored into the bacterial peptido-
glycan layer by the protein A anchor (spaX) from Staphylococcus
aureus. This anchor protein is covalently linked to the tetrapeptides
of the peptidoglycan layer. L. lactis hardly produces any exopolysac-
charide, which granted the availability of the FN fragment to interact
with mammalian cells seeded on the bacterial layer (Fig. 1).
Results
We have first characterised the formation of the L. lactis biofilm on
glass, including the amount of FN that is available for cell interaction.
Then we have addressed the stability of the biofilm after different
days, that results in using a strategy to diminish bacterial metabolism
and prevent uncontrolled proliferation. Afterwards, we have
explored C2C12 interactions on this living interface, first in the
short-term (cell adhesion, cell morphology) and then in the long-
term (differentiation and related signalling).
Characterization of the bacterial-expressed fibronectin. The
Usp45 secretion and spaX (S. aureus protein A) anchor signals
Figure 1 | Schematic of living biointerfaces. C2C12 murine myoblasts were seeded on top of L. lactis biofilms that express a FNIII7-10 fragment as a
membrane protein. The construct features the Usp45 secretion peptide, GFP and the fibronectin fragment FNIII7-10 that contains both RGD (FNIII10)
and PHSRN synergy sites (FNIII9). The construct is inserted into the bacterial peptidoglycan layer by the protein A anchor (spaX). This anchor protein is
covalently linked to the tetrapeptides of the peptidoglycan layer. L. lactis strain forms stable biofilms with very low exopolysaccharide production, which
granted exposure of FN fragments tomammalian cells. C2C12 differentiated intomyoblasts triggered by the FNIII7-10 fragment displayed on the bacterial
membrane.
www.nature.com/scientificreports
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efficiently promote the localization of FNIII7-10 in the bacterial
membrane. We have confirmed the presence of FNIII7-10 by the
tagged GFP, which shows fluorescent rings defining the perimeter
of each bacterium (Supp Fig. S1)8. Fig 2a shows bacterial morphology
at high magnification by SEM. Additional SEM and AFM images are
included in Supp Fig. S1.We have quantified the amount of FNIII7-10
Figure 2 | Visualisation and quantification of FNIII7-10 in the bacterial membrane. (a) Low voltage SEM image of L. lactis-FN adhered to a glass
surface showing the glycocalyx and the adhesion fimbriae. Scale bar size is 200 nm. (b) – (d)Western blot analysis of membrane fractions of L. lactis using
protein extracts from 75, 50 and 25 mL of a stationary phase culture and 750, 500 and 250 ng of a purified FNIII7-10 fragment as standards (quantification
curve shown in d). Proteins isolated from bacteria have higher molecular weight due to GFP, the Usp45 and the spaX fragments (e) Quantification of
FNIII7-10 on the bacteriamembrane using ELISAwithHFN7.1 antibody. Biofilm activity is roughly equivalent to a surface coatedwith a solution of 20 mg/
mL of plasma fibronectin (300 ng/cm2). L. lactis-empty shows negligible fibronectin activity (1000 mL of bacterial culture was used both for L. lactis-
empty and L. lactis-FN, that correspond to a surface area coverage of 27.6 6 8.5%). (f) ELISA of bacterial biofilms (L. lactis-FN) from fresh GM17-E
medium and incubated in DMEMwith tetracycline 10 mg/mL for 1 and 4 days respectively. ANOVA shows no statistically significant differences between
samples. All data presented as mean 6 SD.
www.nature.com/scientificreports
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available on L. lactis membranes using two techniques that provide
complementary information. First, we performed fractionation and
Western blot analysis for bacterial membrane proteins and
subsequent quantification using a recombinant FNIII7-10 fragment
as the part of the bacteria lysate ascribed to membrane proteins
(Fig. 2b). Image analysis of the Western blot bands reveal that the
total amount of FNIII7-10 increases as the volume of the sample
(number of colonies) does. Based on this, the approximate density
of FN fragment per unit volume of bacteria is 0.98 mg/mL, which
corresponds approximately to 9.8 mg/108 CFU (Fig. 2 c,d). However,
considering the role of this living interface in interacting with
mammalian cells, is also important to calculate the availability of
FNIII7-10 after bacteria have been immobilised on a synthetic
material. To do so, we have performed an enzyme-linked
immunosorbent assay (ELISA) with a monoclonal antibody on
high density biofilms, prepared from 1000 mL of culture (Fig. 2e).
This is a well-established method to probe for structural or
conformational changes in adsorbed proteins15,16. We used the
monoclonal HFN7.1 antibody to probe the availability of the
flexible linker between the 9th and 10th type III repeats of FN17.
Figure 2e shows the amount of this integrin-binding domain on
the surface of the living interface is similar to adsorbing FN from a
solution of concentration 20 mg/mL on glass, a surface density of FN
ca. 300 ng/cm2,18,19. As we will use tetracycline containing medium
(TC) to maintain a stable biofilm on the material surface during
experiments with mammalian cells, and since TC might inhibit
bacterial protein expression, we have assessed that there is no
influence of TC on FNIII7-10 expression as a membrane protein
(Fig 2f).
In summary, the engineered living interface presents a high den-
sity of FNIII7-10 available on the cell surface, seeking to promote focal
adhesion organisation and trigger cell fate.
Biofilm formation and stability.We next examined the stability of
the living interface on the material surface. This strain, once the
biofilm has been established, is able to continue proliferating as
long as there is a sufficient supply of nutrients.
L. lactis is a homofermentative strain that metabolises any carbon
source found in the medium, glucose in our experiments, to L-(1)-
lactic acid, in an anaerobic fashion20. This production of lactic acid
leads to a decrease in the pH of the culture medium up to ,4,
seriously compromising the viability of the aboveground cells.
Here arises the need to control the pH of the medium, by inhibiting
the bacterialmetabolism.Wehave found that tetracycline used at low
concentrations, 10 mg/mL, is enough to inhibit the bacterial replica-
tion without impacting mammalian cell metabolism21,22 (Fig 3 and
Figure 3 | Biofilm metabolism and viability. To assess the metabolism of the bacterial community inside the biofilm in conditions compatible with the
culture of C2C12 cells, biofilms of L. lactis-FN and L. lactis-empty were produced. Then, GM17-E medium was changed to either DMEM, DMEM
with 1% penicillin/streptomycin (P/S) or DMEM with 10 mg/mL tetracycline (TC). After 1, 2 and 4 days of culture in DMEM, DMEM1P/S and
DMEM1TC, viability was tested using the LIVE/DEAD BacLight bacterial viability kit, where viable bacteria are stained in green and non-viable in red.
(a) Representative images after 4 days. Scale bar size is 25 mm. (b) Image quantification shows that viability is not affected by either the use of antibiotics or
the culture time. No statistically significant differences among conditions were found. Data is presented as mean 6 SD. (c) Simultaneously, bacterial
metabolism was inferred by measuring the pH of the medium as a function of time, to assess the production of lactic acid. Addition of tetracycline
maintained the pH stable and above 7.5. The use of P/S was enough to maintain the pH above 6.5. In antibiotic-free DMEM, the pH dropped to a
minimum of 4 due to the transformation of glucose in the medium into lactic acid.
www.nature.com/scientificreports
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results on cell differentiation later in this work). Tetracycline is a
broad-spectrum antibiotic that binds to the 30S subunit of themicro-
bial ribosomes, inhibiting the protein synthesis by blocking the
attachment of the charged aminoacyl-tRNA to the ribosomal A site23.
Conversely, penicillin acts inhibiting the peptidoglycan cell-wall
remodelling, ultimately leading to cell breakdown. As we only intend
tomaintain the cell population under control, it is counterproductive
to promote cell lysis, and, as side effect, the modification of the
biofilm morphology. Moreover, tetracycline is more effective con-
trolling the pH at low concentrations and is nontoxic to mammalian
cells21,22 (see also our results on cell behaviour afterwards).
Biofilms of different densities were formed on glass and remained
stable after several days on the material surface. We have effectively
shown that we can control the surface density of bacteria on the
material surface by controlling the seeding volume (Supp Fig. S2).
We selected high-density bacterial cultures to have the highest pos-
sible L. lactis density on the material surface readily available for cell
differentiation experiments. We have assessed the stability of the
layer of bacteria at different time points up to 4 days. This is the time
needed for myogenic differentiation experiment afterwards. Fig. 3
shows live/dead staining for L. lactis grown on glass using different
media (DMEM, DMEM 1 tetracycline (TC), DMEM 1 penicillin
and streptomycin, stated as P/S). After 4 days of culture bacteria
viability (measured by the ration of live to total cells) is unaffected
by the presence of small amounts of antibiotics in the culture med-
ium and it is maintained at ca. 60% (Fig. 3b).
The temporal evolution of the pH in the different media used is
shown in Fig. 3c. Only when the culture medium is supplemented
with TC, acidification does not occur and the pH remains stable for
four days (Fig 3c). We suggest that this acidification of the culture
medium is a consequence of the L. lactismetabolism. As said before,
L. lactis is a homofermentative strain that metabolises any suitable
carbon source found in the medium - glucose in our experiments - to
L-(1)-lactic acid. Then, the production of L-(1)-acid lactic, with a
pKa of 3.8624 must be responsible for the acidification of the culture
medium. Addition of TC maintains a stable pH, which suggests that
no L-lactic acid is produced and that, consequently, bacterial meta-
bolism is inhibited.
The use of antibiotics in the culture medium diminished the den-
sity of bacteria on the material surfaces, as it can be inferred from
Fig. 3a andwe have quantified in Supp Fig. S3. However, even if this is
the case, the layer of bacteria that remains on the surface is viable and
sufficient to support cell adhesion and cell differentiation, as it is
shown afterwards. That is to say, even if the layer of bacteria attained
on thematerial surface is not homogeneous (see e.g. Supp Fig S2), the
attained bacterial surface involves the adequate expression of FN for
mammalian cell interactions.
Cell morphology, adhesion and differentiation on L. lactis. The
density of the biofilm directs area and roundness ofmammalian cells.
We first studied cell morphology on established biofilms of different
densities on glass (Supp Fig. S2). Both cell area and roundness are
directly related to the biofilm density, as shown in fig. 4. C2C12 cells
seeded on biofilms of different densities showed increased area
(Fig. 4b), with minimal changes in cell roundness (Fig. 4c). In
addition, focal adhesions were formed on cells seeded on L. lactis-
FN biofilms. The number of focal adhesion plaques increased with
the density of bacteria on the surface (Supp Fig. S4). These results
suggest that L.lactis–FN directs cell adhesion and cell morphology in
the short-term, which is necessary before considering other long-
term processes such as cell differentiation.
We previously showed that L. lactismodified to express FNIII7-10
as a membrane protein promotes focal adhesion formation and FAK
signalling at similar levels as native FN in fibroblasts8. Now, we
assessed the ability of this living interface to support cell differenti-
ation by examining myogenic differentiation25. Sarcomeric myosin
expression and cell bipolar alignment and fusion into myotubes,
markers of myogenesis, were significantly higher on L. lactis modi-
fied with FNIII7-10 (Fig. 5a) as compared to L. lactis-empty (control
bacteria that do not contain FNIII7-10). Surprisingly, myogenic dif-
ferentiation was higher on the modified L. lactis than on native
fibronectin and collagen type I, which represents the gold-standard
substrate for myogenic differentiation (Fig. 5b)14. It is important to
emphasise that these differences in myogenic differentiation are not
due to differences in the number of cells on the substrates. It is known
that a direct correlation between the number of cells on the surface
and the level of myogenic differentiation has been found, however
the number of cells on the modified bacteria is slightly lower than on
the FN and Col I controls (Fig 5c).
Integrin-mediated cell adhesion triggers a cascade of intracellular
signals such as the p38 mitogen-activated protein kinase (p38
MAPK) pathway, which is involved in the myoblast differentiation
process, by promoting the activity of several transcription factors and
regulating cell cycle withdrawal26,27. An intermediary step between
adhesion and downstream targets, including MAPK pathways, is the
phosphorylation of FAK28; as a result, FAK phosphorylation at
Tyr397 plays a central role during myoblast differentiation in 2D
cultures29,30. Initially, FAK phosphorylation at Tyr397 is transiently
reduced —contributing to trigger the myogenic genetic program—
but it is later activated, as it is central to terminal differentiation into
myotubes30. In order to study the activation of FAK on the L. lactis
expressing FNIII7-10 we examined the phosphorylation of Tyr397 by
Western blot. FAK phosphorylation was similar onmodified L. lactis
and FN-coated glass (Fig 5d e), in good correlation with the high
levels of cell differentiation found in this work (Fig 5b).
These results suggest that enhanced cell differentiation can be
triggered by FNIII7-10 expressed on the membrane of L. lactis. The
fact that the same experiments have been done with L. lactis-empty
strain without significant levels of cell differentiation absolutely con-
firm FNIII7-10 expressed on the bacteria membrane as the trigger of
differentiation.
Discussion
Engineering microenvironments to provide cells with dynamic cues,
as occurs in the natural extracellular matrix, is a field of intensive
research seeking to direct the differentiation of stem cells and ad-
vance in strategies for tissue repair and regeneration31. Several
approaches have been explored spanning from the simple functio-
nalisation ofmaterial surfaces with cell adhesivemotifs to the incorp-
oration of protease-degradable fragments in polymer hydrogels that
allow changes in the material structure as cells secrete proteases to
remodel the ECM7,14,32. Dynamic surfaces have been engineered to
present cell adhesive RGD sequences on-demand6,7,33.
From a different perspective, dynamic cell microenvironments
have been engineered to present and release growth factors in a
sustainable and controlled way to stimulate and support cell differ-
entiation34–40. We have recently shown that non-pathogenic bacteria
can be genetically modified to establish a functional interface
between cells and synthetic materials, and we anticipate that this
living interface could be further modified to instruct cells to perform
different functions in a highly regulated manner8. As an initial step
and proof of concept towards this long-term goal, we engineered8
food-grade Lactococcus lactis, a gram-positive bacterium with very
low production of lipopolysaccharides (LPS) - previously used for
recombinant therapeutic proteins production, therapeutic drug
delivery and vaccine production41 - to present a fibronectin fragment
(FNIII7-10) as a membrane protein. FNIII7-10 contains RGD and the
PHSRN synergy sequences and promote cell adhesion and differ-
entiation42,43. We have previously shown that fibronectin null fibro-
blasts (FN -/-) adhere, spread and develop focal adhesions on this
engineered L. lactis expressing FNIII7-10, in a similar way as when
seeded directly on a FN coating8.
www.nature.com/scientificreports
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Here, we show that this living interface that constitutively express
a FN fragment is able to produce stable biofilms that support cell
growth, cell adhesion and cell differentiation. The formation of the
biofilm starts when some individual cells adhere to the surface, a
process governed by weak non-specific forces - Van der Waals and
polar Lewis acid-base interactions44,45. This initial, reversible attach-
ment becomes irreversible after bacteria make use of several cell-wall
anchored proteins (CWAP) known as adhesins. In L. lactis, the most
prominent ones are the CluA sex factor and the PrtP and NisP
proteinases10,46,47. These adhesins act modifying the bacterial surface
properties and ultimately lead to an irreversible attachment of the
bacteria to the surface. After bacteria attachment becomes irrevers-
ible, the force required to detach additional bacteria increases and
more bacteria are recruited and co-aggregated to the existing ones.
Afterwards, these bacteria proliferate and develop the biofilm itself.
In this phase, a few hours after the initial irreversible attachment, a
stable layer is formed. As L. lactis MG1363 is a strain with a low
production of exopolysaccharides, biofilms are usually monolayered,
lacking the horizontal stratified structure found in other species48,49.
Hence, the formation of L. lactis biofilms seems limited to a thin
layer, usually a monolayer50, of strongly attached bacteria to almost
any abiotic surface, such as polymers, glass or metallic surfaces.
Usually, the adhesion of the bacterium to the substrate is mediated
by the bacterial fimbriae, also called adhesion pili51. These fimbriae
are also involved in the formation of the bacterial aggregates, as
shown in Supp Fig. S1.
Once the biofilm has been successfully established, a need to con-
trol its proliferation arises, and we found that the monolayer can be
controlled to remain in a stationary phase (using low amount of
tetracycline) on the material surface during the time needed to com-
plete the myogenic differentiation process (up to 4 days). We have
quantified the amount of FNIII7-10 that is available on the surface of
the bacterial and verified that it promotes cell adhesion, signalling
and cell differentiation. Overall, this living interface based on non-
Figure 4 | Morphological features of C2C12 myoblasts related to biofilm density. A 3 h culture of C2C12 cells seeded on top of biofilms of different
surface density. Briefly, 10,000 cells/cm2 were seeded on top of L. lactis-FN biofilms of increasing density (covered surface area 4.6%, 11.4%, 19.1% and
27.6%), and L. lactis-empty biofilm produced with an surface density of 27.6%. Afterwards, cells were stained with a monoclonal anti-vinculin antibody
(shown in red), whereas the actin cytoskeleton was stained with phallacidin (in green). Both nuclei of C2C12 cells and bacterial cells are shown in blue. (a)
C2C12 cells seeded over L. lactis-empty biofilm showed no adhesion and remained in their original rounded shape. Cells seeded on L. lactis-FN biofilms
showed good adhesion and well-developed focal adhesion plaques and actin cytoskeleton. Scale bar is 100 mm. (b) Quantification of cell area on the
different biointerfaces suggests a correlation between cell area and the surface density of the biofilm. Area and roundness of at least 450 cells were
quantified using the ImageJ software. (c), Quantification of cell roundness, defined as roundness 5 (4?Area)/(p?(major axis)2). ANOVA test (N$ 400)
shows statistically significant differences between cells seeded on L.lactis-empty, FN-coated surfaces and glass.
www.nature.com/scientificreports
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pathogenic bacteria supports myogenic differentiation. Further gen-
etic modification of this living interface is being currently done to
engineer a dynamic system able to provide cells different temporal
stimuli beyond cell adhesion, such as the delivery of growth factors
and other molecules upon external demand. By engineering non-
pathogenic bacteria to synthesise proteins and growth factors upon
external stimuli, we aim at control the interface between synthetic
biomaterials and stem cells to control self-renewal and differenti-
ation, which can be then applied to several strategies to promote
tissue repair and regeneration.
Methods
Geneticmodification of L. lactis.TheGFP-containing plasmid pGFP-C2 (Clontech)
was used to construct a vector contain ing FNIII7-10 downstream to GFP. FNIII7-10
fragment was amplified from the plasmid pET15b- FNIII7-1052. The forward and
reverse primers used for the FNIII7-10 amplificationwere F1, withHindIII restriction
site:
aagcttaCCATTGTCTCCACCAACAAAC, and R1, with SalI restriction site:
gtcgacttaTTCTGTTCGGTAATTAATGGAAA. The lactococcal plasmid PT1NX
was used to clone the GFP- FNIII7-10 fragment using the following primers: F2, with
NgomIV restriction site gccggcATGGGTAAAGGAGAAGAACTTT; and R2:
TTCTGTTCGGTAATTAATGGAAA. Lactococcus lactis MG136353 containing
the PT1NX plasmid was grown as standing culture, in anaerobic conditions, at 30uC
in M17 medium (Oxoid, Basingstoke, UK) supplemented with glucose (0.5% v/v,
Sigma) and erythromycin (10 mg/mL, Sigma-Aldrich) (hereinafter GM17-E). The
plasmid extraction was carried using a protocol described elsewhere8. Competent L.
lactis MG1363 cells were prepared growing the cells in rich medium supplemented
with glycine (1% v/v). Cells were harvested when the culture reached an optical
density of 0.6–0.8 measured at 600 nm, resuspended in glucose (0.5 M) with glycerol
(10% v/v) and frozen at 280uC. Electroporation was performed at 2.5 kV using a
BTX electroporator (Harvard Apparatus). In these conditions, with desalted DNA,
the typical time constant was 4.5. Electroporated cells were transferred directly to
5 mL medium composed of M17, glucose (0.5 M), MgCl2 (20 mM) and CaCl2
Figure 5 | Myogenic differentiation and cell signalling on living biointerfaces. (a) Fluorescence staining after 4 days of culture showing sarcomeric
myosin-positive cells (green) and cell nuclei (red) on L. lactis-FN, L. lactis-empty, collagen I (1 mg/mL) coated glass, and FN (20 mg/mL) coated glass.
Scale bar is 25 mm. (b) Myogenic differentiation as determined by the percentage of sarcomeric myosin-positive cells on the different interfaces. Higher
degree of differentiation was found on L. lactis-FN compared to collagen I and FN coated glass. (c) C2C12 cell density on biofilms and control substrates
(d) Representative western blot bands for pFAK and FAK on the different biointerfaces. (e) Quantification of western blot bands. ANOVA test shows
statistically significant differences between each column. Data is presented as mean 6 SD.
www.nature.com/scientificreports
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(2 mM) and incubated for 2 h at 30uC. The resultant culture was centrifuged,
resuspended in 50 mL of the later medium and extended on GM17-E agar plates.
Biofilm formation. The protocol to establish a biofilm on the material surface has
been published elsewhere54,55. Briefly, Lactococcus lactis MG1363 containing the
PT1NX- FNIII7-10 -GFP plasmid8 (hereinafter L. lactis-FN) and L. lactis containing
the PT1NX empty vector (L. lactis-empty) were grown as standing cultures in GM17-
E broth at 30uC. Then, 1 mL of each culture was used to streak fresh GM17-E agar
plates (1% w/v agar). The plates were kept at 30uC for 24 h. A single colony from a
GM17-E agar plate was inoculated into sterile GM17-E broth (Oxoid). The culture
was grown until OD660, 0.3, and then transferred to a P24multiwell plate containing
sterile glass coverslips in each well, using 300 mL and 1000 mL respectively in order to
produce low and high areal density biofilms. The multiwell plate was sealed with
Parafilm and left at 30uC in anaerobic conditions for 48 h. After that, the planktonic
(non-adhered) bacteria were removed by shaking the multiwell plate at 150 rpm for
3 min followed with three washing steps with sterile ultrapure water. In the last wash,
the ultrapure water was substituted with PBS supplemented with CaCl2 and MgCl2
(PBS11). The same protocol was used for empty and FN-expressing strains.
Biofilm viability and metabolism. For bacterial viability studies, after 1, 2 or 4 days,
biofilmswere gently washed twice with sterile NaCl 0.85%w/v solution and incubated
for 30 min using the BacLight LIVE/DEAD kit (Life Technologies), containing
SYTO9 (5 mM) and propidium iodide (30 mM) in NaCl 0.85% w/v. Afterwards,
samples were washed and mounted using BacLight Oil mounting medium (Life
Technologies). Bacteria were counted using Fiji – ImageJ software56, using at least four
microscope fields at 403 magnification for every sample. The viability was
determined as the ratio between the viable and total number of bacteria.
For metabolism analysis, biofilms were prepared following the biofilm formation
protocol. Afterwards, the medium was changed to either DMEM or DMEM con-
taining tetracycline (TC, 10 mg/mL)) or DMEM containing 1% penicillin-strep-
tomycin (P/S). Biofilmswere kept at 37uC in a humidified atmosphere under 5%CO2,
and the pH was monitored as a function of time (0, 0.5, 1, 1.5, 2, 3, 4, 5, 24 and 48 h)
using a pH-meter (Eutech Instruments).
AFM and SEM imaging of the biofilms. For SEM imaging, bacterial biofilms were
produced as described in the biofilm formation section. Freshly washed biofilms were
fixed in 2.5% glutaraldehyde in phosphate buffer (PB, 0.1 M, pH 7.3) for 14 hours at
4uC. Then, biofilms were washed twice with PB and dehydrated in an ethanol/water
mixture of 50%, 70%, 80%, 90%, 95% and 100% for 10 minutes each. The 100%
ethanol step was repeated three times. Afterwards, samples were immersed twice in
hexamethyldisilazane (Sigma) and air-dried for 10 minutes57. Samples were stored in
vacuum until imaging in the microscope. Prior to imaging, samples were sputter-
coated with a 1 nm layer of platinum and observed in a Zeiss Ultra 55 Field Emission
SEM (Zeiss Microscopy, Germany) with 1 kV of gun acceleration voltage.
For AFM, a culture in stationary phase was washed twice with sodium acetate
(100 mM, pH 4.8) and three millilitres of the resulting bacterial suspension with the
same bacterial density as the original culture were filtered through a porous poly-
carbonate membrane with a mean pore size of 0.8 mm (Millipore). The membrane
was gently washed with the same sodium acetate solution to remove the non-trapped
bacteria, while avoiding dewetting58. The wet sample was imaged in a Multimode
AFM equipped with a NanoScope IIIa controller from Veeco (Manchester, UK) in
QNM mode. Si cantilevers from Veeco were used, with a force constant of 0.7 N/m.
Drive amplitude was 100 mV and amplitude setpoint was 250 mV.
Surface density of FN - ELISA. 3 mL from a 24 h standing culture of L. lactis-FN and
L. lactis-empty grown in sterile GM17-E, with a bacterial density of 107 cfu/mL, were
filtered through a porous polycarbonate membrane with a mean pore size of 0.8 mm
(Isopore, Millipore). The membrane was washed twice with PBS11 to remove the
non-trapped bacterial cells. Another set of membranes was coated with 20, 10, 5 and
2.5 mg/mL of human plasma fibronectin (Sigma) in PBS11 for 1 h at RT, and
washed twice with PBS11. Uncoated membranes were used to assess the absence of
any background signal in the polycarbonate membranes. Membranes were then
blocked with 1% bovine serum albumin (Sigma) in PBS11 for 1 h at RT, and
incubated for 1 h at 37uCwithmonoclonal mouse HFN7.1 anti-fibronectin antibody.
The primary antibody dilution was 154000 from a 32 mg/mL antibody stock. After
that, samples were washed twice with PBS11/Tween 20 (0.5% v/v) and incubated
with ALP-conjugated donkey anti-mouse secondary antibody (Jackson
Immunoresearch) for 1 h at RT. Samples were washed again twice with PBS11/
Tween 20 (0.5% v/v), and 400 mL of 4-methylumbelliferyl phosphate (0.6 mM,
Sigma) in borax/NaOH pH 10 buffer was added. After 45 min at 37uC, the
supernatant was transferred to a P96 multiwell plate. Fluorescence was measured at
365/460 nm (excitation/emission wavelengths) with a Perkin-Elmer Victor3
Multilabel Counter (Perkin Elmer).
Surface density of FN -Western blot.Three aliquots of 1.5, 1 and 0.5 mL from a 24 h
standing culture of both L. lactis-FN and L. lactis-empty strains inGM17-Ewere lysed
using a modified acetone/SDS protocol59. Briefly, cells were harvested by
centrifugation at 7000 g for 5 min, washed twice with PBS without Mg21 and Ca21
and centrifuged again. The pellet was treated with 1 mL of acetone at -20uC for
10 min, with occasional vigorous vortexing. The extract was centrifuged at 7000 g for
5 min and carefully dried under a gentle stream of N2 until a porous, dry white
powder was obtained. Proteins were solubilised by incubating the previously obtained
powder with 100 mL of SDS (1% w/v) for 20 min at RT, with occasional vortexing.
Debris were pelleted by centrifugation at 7000 g for 5 min. 20 mL of the supernatant
was mixed with 20 mL of 2x Laemmli buffer and boiled for 5 min at 95uC, and
samples were loaded on 10% SDS-PAGE gels. Simultaneously, 750, 500 and 250 ng of
a purified fragment of FNIII7-10 were loaded in the same gel as controls. Proteins were
transferred to a positively charged PVDF membrane (GE Healthcare) using a semi-
dry transfer cell system (Bio-Rad). Membranes were blocked using 5% skimmedmilk
in PBS for 1 hour at RT and then incubated with the MAB1937 antibody (Millipore)
directed against the 8th type III repeat in human FN diluted 151000 in PBS
containing Tween 20 (0.1% v/v) and skimmedmilk (2%w/v), overnight, at 4uC. After
several washes with PBS/Tween 20 (0.1% v/v), the blot was incubated using
horseradish peroxidase-conjugated anti-mouse antibody (GE Healthcare) diluted
1550,000 in PBS/Tween 20 (0.1% v/v)/skimmed milk (2% w/v) for 1 h at RT.
Membranes were washed several times with Tween 20 (0.5% v/v) in PBS. The
immunoreactive bands were visualized using the ECL Plus Western blot kit (GE
Healthcare).
C2C12-biofilm co-culture. C2C12 cells (American Type Culture Collection) were
maintained in DMEM medium with 20% Foetal Bovine Serum (FBS) and 1%
penicillin-streptomycin. Then, they were seeded over freshly washed biofilms at
20.000 cells per cm2. The culture was maintained 3 h at 37uC in a humidified
atmosphere under 5% CO2 to ensure initial adhesion to the biofilm. After 3 h, the
medium was changed to DMEM with 1% ITS (insulin-transferrin-selenium, Life
Technologies) and tetracycline (10 mg/mL, Sigma-Aldrich) to maintain the
proliferation of the bacteria under control and prevent the acidification of the culture
medium by lactic acid production. The culture was kept for 4 days at 37uC and 5%
CO2 in a humidified atmosphere.
Immunofluorescence. Cultures were fixed at 4uC with 70% ethanol, 37%
formaldehyde and glacial acetic acid (205251) for 15 min and then blocked with 5%
goat serum in PBS11 for 1 h at RT. The samples were incubated with MF-20
antibody against sarcomeric myosin (Developmental Studies Hybridoma Bank,
University of Iowa, USA) at 15250 dilution in PBS11 and 5% goat serum, followed
by two washes with PBS11/Tween 20 (0.5% v/v) and another blocking step with 5%
goat serum in PBS11 for 10 min at RT. Then were washed twice with PBS11/
Tween 20 (0.5% v/v) and incubated with rabbit anti-mouse Cy3-conjugated
secondary antibody (Jackson Immunoresearch) at 15200 dilution in PBS11with 5%
goat serum. Samples were then washed three times with PBS11/Tween 20 (0.5% v/
v), mounted with Vectashield-DAPI, and observed under an epifluorescence
microscope (Nikon Eclipse 80i).
Images from the fluorescencemicroscope (DAPI channel - nuclei, andCy3 channel
- sarcomeric myosin) of the C2C12 culture were acquired at 103 magnification,
transformed to an 8-bit grayscale bitmap (Fiji - ImageJ software) and segmented
using the Trainable Weka Segmentation plugin to create a binary mask, for both
DAPI and Cy3 channels. Total nuclei per image were counted using the particle
analysis command. Then, the segmented DAPI channel image was subtracted from
the Cy3 channel segmented image, and the remaining nuclei were counted and
assigned to non-differentiated cells. The fraction of differentiated cells was calculated
subtracting the non-differentiated nuclei from the total nuclei count.
For vinculin and actin visualisation, a slightly different protocol was used. Cell
fixation was performed using formalin for 30 min at 4uC. Then cells were blocked
with 1% BSA in PBS11. A monoclonal anti-vinculin antibody (Sigma), diluted
15400 in BSA 1%/PBS11 was used as primary antibody. The incubation lasted
1 hour at RT. Then, cells were washed twice with PBS11/Tween 20 (0.5% v/v), and
incubated with rabbit anti-mouse Cy3 conjugated (Jackson Immunoresearch), 15200
dilution, with FITC-conjugated phallacidin (Life Technologies) diluted 15100 in 1%
BSA/PBS11/Tween 20 (0.5% v/v). The secondary antibody was incubated 1 hour at
RT in absence of light. Cells were washed three times with PBS/Tween 20 (0.5% v/v)
and mounted with Vectashield-DAPI (Vector Laboratories).
FAK phosphorylation. After 3 hours of culture, cells were lysed with RIPA buffer
(Tris-HCl 50 mM, 1% Nonidet P-40, 0.25% Na deoxycholate, 150 mMNaCl, 1 mM
EDTA) supplemented with protease inhibitor cocktail tablets (Complete, Roche).
Proteins were concentrated using Microcon YM-30 Centrifugal Filter devices
(Millipore) as manufacturer described. To determine FAK protein expression and its
Tyr397 phosphorylated form (pFAK), concentrated samples were subjected to 7%
SDS-PAGE gel electrophoresis. Proteins were transferred to a positively charged
PVDFmembrane (GEHealthcare) using a semidry transfer cell system (Bio-Rad) and
blocked by immersion in skimmedmilk (5%w/v) in PBS for 1 h at room temperature.
The blot was incubated with anti-FAK antibody (Upstate) and anti-pFAK antibody
(Millipore) diluted 152500 in PBS containing Tween 20 (0.1%) and skimmed milk
(2%). After several washes with PBS/Tween 20 (0.1% v/v), the blot was incubated in
horseradish peroxidase-conjugated antibody (GE Healthcare) diluted 1550000 in
PBS/Tween 20 (0.1% v/v) and milk (2% w/v) for 1 hour at room temperature. After
several washes with PBS containing Tween (0.1% v/v) and milk (2% w/v),
immunoreactive bands were visualized using Supersignal West-femto Maximum
Sensitivity Substrate (Thermo Scientific).
Statistical analysis. All data presented in this paper are shown as mean 6 SD.
Figure 4b and 4c (cell area and cell roundness): A D’Agostino & Pearson omnibus
normality test was performed, finding that the data do not follow a Gaussian
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distribution. Then, a non-parametric ANOVA followed by a Kruskal-Wallis (Dunn)
multiple comparison test was performed, with p 5 0.05.
Figure 5b and 5e, corresponding to the C2C12 differentiation assay and cell
density respectively: A D’Agostino & Pearson omnibus normality test was done,
finding that the data follows a Gaussian distribution. Then, a one-way ANOVA
with p 5 0.05 followed by a Tukey multiple column comparison test was per-
formed.
1. Sipe, J. D. Tissue engineering and reparative medicine.Ann N YAcad Sci 961, 1–9
(2002).
2. Griffith, L., Naughton, G. & Naughton, G. Tissue engineering--current challenges
and expanding opportunities. Science (80-) 295, 1009 (2002).
3. Grinnell, F. Focal adhesion sites and the removal of substratum-bound
fibronectin. J Cell Biol 103, 2697–2706 (1986).
4. Lutolf, M., Gilbert, P. & Blau, H. Designing materials to direct stem-cell fate.
Nature 462, 433–441 (2009).
5. Petrie, T., Raynor, J., Dumbauld, D., Lee, T. & Jagtap, S. Multivalent Integrin-
Specific Ligands Enhance Tissue Healing and Biomaterial Integration. Sci Transl
Med 2, 45ra60 (2010).
6. Weis, S., Lee, T. T., del Campo, A. & Garcı´a, A. J. Dynamic cell-adhesive
microenvironments and their effect on myogenic differentiation. Acta Biomater
9, 8059–66 (2013).
7. Todd, S. J., Scurr, D. J., Gough, J. E., Alexander, M. R. & Ulijn, R. V. Enzyme-
activated RGD ligands on functionalized poly(ethylene glycol) monolayers:
surface analysis and cellular response. Langmuir 25, 7533–7539 (2009).
8. Saadeddin, A. et al. Functional living biointerphases.AdvHealthcMater 2, 1213–8
(2013).
9. Aota, S., Nomizu, M. & Yamada, K. M. The short amino acid sequence Pro-His-
Ser-Arg-Asn in human fibronectin enhances cell-adhesive function. J Biol Chem
269, 24756–61 (1994).
10. Habimana, O. et al. Positive role of cell wall anchored proteinase PrtP in adhesion
of lactococci. BMC Microbiol 7, 36 (2007).
11. Mercier, C. et al. Positive role of peptidoglycan breaks in lactococcal biofilm
formation. Mol Microbiol 46, 235–43 (2002).
12. Garcı´a, A. J. Get a grip: integrins in cell-biomaterial interactions. Biomaterials 26,
7525–9 (2005).
13. Hynes, R. O. Integrins: Bidirectional, Allosteric Signaling Machines. Cell 110,
673–687 (2002).
14. Garcı´a, A. J., Vega, M. D. & Boettiger, D. Modulation of cell proliferation and
differentiation through substrate-dependent changes in fibronectin
conformation. Mol Biol Cell 10, 785–98 (1999).
15. Ugarova, T. P. et al. Conformational transitions in the cell binding domain of
fibronectin. Biochemistry 34, 4457–4466 (1995).
16. McClary, K. B., Ugarova, T. & Grainger, D. W. Modulating fibroblast adhesion,
spreading, and proliferation using self-assembled monolayer films of
alkylthiolates on gold. J Biomed Mater Res 50, 428–439 (2000).
17. Schoen, R. C., Bentley, K. L. & Klebe, R. J. Monoclonal antibody against
human fibronectin which inhibits cell attachment. Hybridoma 1, 99–108
(1982).
18. Keselowsky, B. G., Collard, D. M. & Garcı´a, A. J. Surface chemistry modulates
fibronectin conformation and directs integrin binding and specificity to control
cell adhesion. J Biomed Mater Res A 66, 247–59 (2003).
19. Salmero´n-Sa´nchez, M. et al. Role of material-driven fibronectin fibrillogenesis in
cell differentiation. Biomaterials 32, 2099–105 (2011).
20. Oliveira, A. P., Nielsen, J. & Fo¨rster, J. Modeling Lactococcus lactis using a
genome-scale flux model. BMC Microbiol 5, 39 (2005).
21. Rivadeneira, J., Di Virgilio, A. L., Audisio, M. C., Boccaccini, A. R. & Gorustovich,
A. A. Evaluation of antibacterial and cytotoxic effects of nano-sized bioactive
glass/collagen composites releasing tetracycline hydrochloride. J Appl Microbiol
1–9 (2014). doi:10.1111/jam.12476.
22. Bacon, J. A., Linseman, D. A. & Raczniak, T. J. In vitro cytotoxicity of tetracyclines
and aminoglycosides in LLC-PK(1), MDCK and Chang continuous cell lines.
Toxicol In Vitro 4, 384–8 (1990).
23. Connell, S. R., Tracz, D. M., Nierhaus, K. H. & Taylor, D. E. Ribosomal protection
proteins and their mechanism of tetracycline resistance. Antimicrob Agents
Chemother 47, 3675–3681 (2003).
24. Dawson, R. Data for biochemical research (Oxford University Press, Oxford,
1989).
25. Sabourin, L. A. & Rudnicki, M. A. The molecular regulation of myogenesis. Clin
Genet 57, 16–25 (2001).
26. Mancini, A. et al. Regulation of myotube formation by the actin-binding factor
drebrin. Skelet Muscle 1, 36 (2011).
27. Sastry, S. K. et al. Quantitative changes in integrin and focal adhesion signaling
regulate myoblast cell cycle withdrawal. J Cell Biol 144, 1295–1309 (1999).
28. Chatzizacharias, N. A., Kouraklis, G. P. & Theocharis, S. E. Disruption of FAK
signaling: A side mechanism in cytotoxicity. Toxicology 245, 1–10 (2008).
29. Clemente, C. F. M. Z., Corat, M. A. F., Saad, S. T. O. & Franchini, K. G.
Differentiation of C2C12 myoblasts is critically regulated by FAK signaling. Am J
Physiol Regul Integr Comp Physiol 289, R862–R870 (2005).
30. Quach, N. L. & Rando, T. A. Focal adhesion kinase is essential for
costamerogenesis in cultured skeletal muscle cells. Dev Biol 293, 38–52
(2006).
31. Kirschner, C. M., Alge, D. L., Gould, S. T. & Anseth, K. S. Clickable,
Photodegradable Hydrogels to Dynamically Modulate Valvular Interstitial Cell
Phenotype. Adv Healthc Mater (2014) doi:10.1002/adhm.201300288.
32. Khetan, S. et al. Degradation-mediated cellular traction directs stem cell fate in
covalently crosslinked three-dimensional hydrogels. Nat Mater 12, 458–65
(2013).
33. Ulijn, R. V. Enzyme-responsive materials: a new class of smart biomaterials.
J Mater Chem 16, 2217 (2006).
34. Makarenkova, H. et al. Differential interactions of FGFs with heparan sulfate
control gradient formation and branching morphogenesis. Sci Signal 2, ra55
(2009).
35. Silva, A. K., Richard, C., Bessodes, M., Scherman, D. & Merten, O. W. Growth
factor delivery approaches in hydrogels. Biomacromolecules 10, 9–18 (2009).
36. Lutolf, M. P. & Hubbell, J. A. Synthetic biomaterials as instructive extracellular
microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 23,
47–55 (2005).
37. Hahn, M. S., Miller, J. S. & West, J. L. Three-dimensional biochemical and
biomechanical patterning of hydrogels for guiding cell behavior. Adv Mater 18,
2679–1 (2006).
38. Moon, J. J., Hahn, M. S., Kim, I., Nsiah, B. A. & West, J. L. Micropatterning of
poly(ethylene glycol) diacrylate hydrogels with biomolecules to regulate and
guide endothelial morphogenesis. Tissue Eng A 15, 579–585 (2009).
39. Phelps, E. A., Landazuri, N., Thule, P.M., Taylor,W. R. &Garcı´a, A. J. Bioartificial
matrices for therapeutic vascularization. Proc Natl Acad Sci U S A 107, 3323–3328
(2010).
40. Patterson, J., Martino, M. M. & Hubbell, J. A. Biomimetic materials in tissue
engineering. Mater Today 13, 14–22 (2010).
41. Cortes-Perez, N. G., da Costa Medina, L. F., Lefevre, F., Langella, P. & Bermudez-
Humaran, L. G. Production of biologically active CXC chemokines by
Lactococcus lactis: evaluation of its potential as a novel mucosal vaccine adjuvant.
Vaccine 26, 5778–5783 (2008).
42. Cutler, S. M. & Garcı´a, A. J. Engineering cell adhesive surfaces that direct integrin
a5b1 binding using a recombinant fragment of fibronectin. Biomaterials 24,
1759–1770 (2003).
43. Rico, P., Gonza´lez-Garcı´a, C., Petrie, T. A., Garcı´a, A. J. & Salmero´n-Sa´nchez, M.
Molecular assembly and biological activity of a recombinant fragment of
fibronectin (FNIII7–10) on poly(ethyl acrylate). Colloids Surfaces B Biointerfaces
78, 310–316 (2010).
44. Van Oss, C. J., Good, R. J. & Chaudhury, M. K. The role of van der Waals forces
and hydrogen bonds in ‘‘hydrophobic interactions’’ between biopolymers and low
energy surfaces. J Colloid Interface Sci 111, 378–390 (1986).
45. Van Loosdrecht, M. C., Lyklema, J., Norde, W., Schraa, G. & Zehnder, A. J.
Electrophoretic mobility and hydrophobicity as a measured to predict the initial
steps of bacterial adhesion. Appl Environ Microbiol 53, 1898–1901 (1987).
46. Godon, J.-J., Jury, K., Shearman, C. A. & Gasson, M. J. The Lactococcus lactis sex-
factor aggregation gene cluA. Mol Microbiol 12, 655–663 (1994).
47. Giaouris, E., Chapot-Chartier, M.-P. P. & Briandet, R. Surface physicochemical
analysis of natural Lactococcus lactis strains reveals the existence of hydrophobic
and low charged strains with altered adhesive properties. Int J FoodMicrobiol 131,
2–9 (2009).
48. Gulot, E. et al. Heterogeneity of diffusion inside microbial biofilms determined by
fluorescence correlation spectroscopy under two-photon excitation. Photochem
Photobiol 75, 570–578 (2002).
49. Habimana, O.,Meyrand,M.,Meylheuc, T., Kulakauskas, S. & Briandet, R. Genetic
features of resident biofilms determine attachment of Listeria monocytogenes.
Appl Environ Microbiol 75, 7814–7821 (2009).
50. Rieu, A. et al. Listeria monocytogenes EGD-e biofilms: no mushrooms but a
network of knitted chains. Appl Environ Microbiol 74, 4491–4497 (2008).
51. Oxaran, V. et al. Pilus biogenesis in Lactococcus lactis: molecular characterization
and role in aggregation and biofilm formation. PLoS One 7, e50989 (2012).
52. Petrie, T. A., Capadona, J. R., Reyes, C. D. & Garcı´a, A. J. Integrin specificity and
enhanced cellular activities associated with surfaces presenting a recombinant
fibronectin fragment compared to RGD supports. Biomaterials 27, 5459–70
(2006).
53. Schotte, L. Secretion of biologically active murine interleukin-10 by Lactococcus
lactis. Enzyme Microb Technol 27, 761–765 (2000).
54. Burmølle, M. et al. Enhanced biofilm formation and increased resistance to
antimicrobial agents and bacterial invasion are caused by synergistic interactions
in multispecies biofilms. Appl Environ Microbiol 72, 3916–3923 (2006).
55. Zaidi, A. H., Bakkes, P. J., Krom, B. P., van der Mei, H. C. & Driessen, A. J. M.
Cholate-stimulated biofilm formation by Lactococcus lactis cells. Appl Environ
Microbiol 77, 2602–10 (2011).
56. Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis.Nat
Methods 9, 676–82 (2012).
57. Araujo, J. C. Comparison of hexamethyldisilazane and critical point drying
treatments for SEM analysis of anaerobic biofilms and granular sludge. J Electron
Microsc (Tokyo) 52, 429–433 (2003).
58. Dufreˆne, Y. F. Atomic force microscopy and chemical force microscopy of
microbial cells. Nat Protoc 3, 1132–8 (2008).
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 4 : 5849 | DOI: 10.1038/srep05849 9
59. Bhaduri, S. Modification of an acetone-sodium dodecyl sulfate disruptionmethod
for cellular protein extraction from neurotoxigenic Clostridium botulinum.
Foodborne Pathog Dis 9, 172–4 (2012).
Acknowledgments
The support from ERC through HealInSynergy 306990 is acknowledged.
Author contributions
A.R.N. and M.S.S. designed the research. A.R.N. performed it and prepared all figures.
A.R.N., P.R., A.S., A.J.G. and M.S.S. analysed the data. A.R.N. and M.S.S. wrote the paper.
Additional information
Supplementary information accompanies this paper at http://www.nature.com/
scientificreports
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Rodrigo-Navarro, A., Rico, P., Saadeddin, A., Garcia, A.J. &
Salmero´n-Sa´nchez, M. Living biointerfaces based on non-pathogenic bacteria to direct cell
differentiation. Sci. Rep. 4, 5849; DOI:10.1038/srep05849 (2014).
This work is licensed under a Creative Commons Attribution-NonCommercial-
NoDerivs 4.0 International License. The images or other third party material in
this article are included in the article’s Creative Commons license, unless indicated
otherwise in the credit line; if the material is not included under the Creative
Commons license, users will need to obtain permission from the license holder
in order to reproduce the material. To view a copy of this license, visit http://
creativecommons.org/licenses/by-nc-nd/4.0/
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 4 : 5849 | DOI: 10.1038/srep05849 10
